A public database created by the Centers for Medicare & Medicaid Services (CMS) in the United States, disclosing financial relationships between healthcare providers, pharmaceutical companies, and device manufacturers.
A provision of the Affordable Care Act requiring transparency in financial relationships within the healthcare industry, leading to the creation of the Open Payments Data program.
Individuals or entities involved in delivering healthcare services, including physicians, dentists, hospitals, and other healthcare professionals.
Healthcare providers who are eligible to receive payments or transfers of value, including direct payments, gifts, travel reimbursements, and more.
Pharmaceutical companies, biotechnology firms, and medical device manufacturers that are required to report payments and transfers of value to covered recipients.
A hospital that has a medical residency program, eligible for reporting payments and transfers of value related to physician education and training.
Financial transactions or items of value exchanged between applicable manufacturers and covered recipients, encompassing research funding, speaking fees, meals, and other forms of compensation.
Funds provided by applicable manufacturers to healthcare providers for conducting clinical trials, studies, or research projects.
The disclosure of any financial interests or ownership stakes physicians may have in applicable manufacturers or group purchasing organizations.
Categorization of payments and transfers of value based on their purpose, such as consulting fees, royalty payments, honoraria, or charitable contributions.
The total amount of payments and transfers of value made by applicable manufacturers to covered recipients, providing an overview of financial relationships.
Information within the Open Payments Data set that has been stripped of personally identifiable details to protect the privacy of individuals.